Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001999371-25-006966·Affinity Asset Advisors, LLC
Schedule 13G ownership disclosure
Ventyx Biosciences Inc
Common Stock, par value $0.0001 per share · CUSIP: 92332V107
Event date: 2025-05-22
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Affinity Healthcare Fund, LP
Shares: 4,057,105.00 · Class: 5.70%
- Affinity Asset Advisors, LLC
Shares: 4,057,105.00 · Class: 5.70%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001999371-25-006966
- Form type
- SCHEDULE 13G
- Filer
- Affinity Asset Advisors, LLC
- CIK
- CIK 1773195
- Filed
- May 30, 2025
- Reporting period
- May 22, 2025
- Description
- Schedule 13G beneficial ownership